Related Experiment Video
Updated: Jul 19, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Statins in Cancer Prevention and Therapy
Natalia Ricco1, Stephen J Kron2
1Basic Sciences Department, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, 08195 Barcelona, Spain.
Abstract:
Statins, a class of HMG-CoA reductase inhibitors best known for their cholesterol-reducing and cardiovascular protective activity, have also demonstrated promise in cancer prevention and treatment. This review focuses on their potential applications in head and neck cancer (HNC), a common malignancy for which established treatment often fails despite incurring debilitating adverse effects. Preclinical and clinical studies have suggested that statins may enhance HNC sensitivity to radiation and other conventional therapies while protecting normal tissue, but the underlying mechanisms remain poorly defined, likely involving both cholesterol-dependent and -independent effects on diverse cancer-related pathways. This review brings together recent discoveries concerning the anticancer activity of statins relevant to HNC, highlighting their anti-inflammatory activity and impacts on DNA-damage response. We also explore molecular targets and mechanisms and discuss the potential to integrate statins into conventional HNC treatment regimens to improve patient outcomes.
Insights
Statins show promise in head and neck cancer (HNC) treatment by potentially increasing sensitivity to therapies and protecting normal tissues. Further research into their anti-inflammatory and DNA-damage response mechanisms could improve HNC patient outcomes.
Area of Science:
- Oncology
- Pharmacology
Background:
- Head and neck cancer (HNC) presents significant treatment challenges with severe adverse effects.
- Statins, known for cholesterol reduction, exhibit potential anticancer properties.
Purpose of the Study:
- To review the anticancer activities of statins in head and neck cancer (HNC).
- To explore the mechanisms underlying statin efficacy in HNC treatment.
- To discuss the integration of statins into HNC therapeutic strategies.
Main Methods:
- Review of preclinical and clinical studies on statins in HNC.
- Analysis of molecular pathways, including cholesterol-dependent and -independent effects.
- Examination of anti-inflammatory and DNA-damage response mechanisms.
Main Results:
- Statins may enhance HNC sensitivity to conventional therapies like radiation.
- Statins show potential in protecting normal tissues from treatment-related damage.
- Evidence suggests both cholesterol-dependent and -independent mechanisms are involved.
Conclusions:
- Statins offer a promising adjunctive therapy for head and neck cancer.
- Understanding statin's molecular targets can optimize their use in HNC treatment.
- Integrating statins may improve outcomes for HNC patients suffering from debilitating effects.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Prevention
Some...
Atherosclerosis III: Management
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cholesterol: Significance and Regulation
Considering cholesterol and...

